Abstract
Background: Despite increasing use of percutaneous, transcatheter approaches, endoscopic mitral valve surgery (MVS) remains the gold standard for treatment of mitral regurgitation. Nevertheless, as perioperative risk increases with age, outcome of MVS in elderly patients is uncertain.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
